(USD) | Sep 2023 | Q/Q |
---|---|---|
Revenue | 2.2MM | -3% |
Gross Profit | 395K | -16% |
Cost Of Revenue | 1.8MM | -0% |
Operating Income | -1.6MM | -10% |
Operating Expenses | 2MM | -11% |
Net Income | -3.7MM | +56% |
R&D | 266K | -31% |
G&A | 1.7MM | -7% |
Interest Expense | 2.1MM | - |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
We feel now is a pretty good time to analyse ThermoGenesis Holdings, Inc.'s ( NASDAQ:THMO ) business as it appears the...
Key Insights ThermoGenesis Holdings will host its Annual General Meeting on 14th of December Salary of US$519.0k is...
ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q3 2023 Earnings Call Transcript November 13, 2023 Operator: Good day. And welcome to the ThermoGenesis Holdings Conference Call and Webcast to Review Financial and Operating Results for the Third Quarter ended September 30, 2023. As a reminder, this call is being recorded today. I would now like to turn the […]
Q3 2023 Thermogenesis Holdings Inc Earnings Call
ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today reported financial and operating results for the third quarter ended September 30, 2023, and provided a corporate business update.
ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the third quarter ended September 30, 2023, and provide a corporate strategic update on Thursday, November 13, 2023, after the close of trading. A conference call and webcast will follow at 1:30 p.m. PT/ 4:30 p.m. ET.
ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing and cell and gene therapy services, announced the grand opening of its new state-of-the-art facility, housing ISO 7 cGMP cleanroom suites, along with research and development labs. The Grand Opening Celebration for the ReadyStart Cleanrooms and IncuStart Wet Labs was held today at the facility located at 2890 Kilgore Rd., Rancho Cordova, CA 95670.
ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that Chris Xu, Ph.D., Chief Executive Officer, will present a company overview on Wednesday, September 13, at 4:30 pm ET, during the H.C. Wainwright 25th Annual Global Investment Conference, taking place September 11-13, 2023, in New York.
ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q2 2023 Earnings Call Transcript August 11, 2023 Operator: Good day, and welcome to the ThermoGenesis Holdings conference call and webcast to review financial and operating results for the second quarter ended June 30, 2023. [Operator Instructions]. As a reminder, this conference call is being recorded. I would now like to […]
Q2 2023 Thermogenesis Holdings Inc Earnings Call